Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 244

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 244
---
 expressed in the Securities Act and is
therefore unenforceable.

<div align='center'>131

Principal Shareholders</div>

The following table sets forth information regarding
the beneficial ownership of our ordinary shares as of the date of this prospectus, and as adjusted to reflect the sale of our Class A
ordinary shares included in the units offered by this prospectus, and assuming no purchase of units in this offering, by:

| · | each                                                                                        
 person known by us to be the beneficial owner of more than 5% of our issued and outstanding 
 ordinary shares;                                                                            |

| · | each                                                  
 of our officers, directors and director nominees; and |

| · | all                                    
 our officers and directors as a group. |

Unless otherwise indicated, we believe that all
persons named in the table have sole voting and investment power with respect to all of our ordinary shares beneficially owned by them.
The following table does not reflect record or beneficial ownership of the private placement warrants as these warrants are not exercisable
within 60 days of the date of this prospectus.

Pursuant to certain subscription agreements dated
October 29, 2024, on November 12, 2024, our initial shareholders paid an aggregate of $25,000, or approximately $0.004 per
share, to cover certain of our offering costs in exchange for an aggregate of 5,750,000 founder shares.

Prior to the initial investment in the company
of $25,000 by our initial shareholders, the company had no assets, tangible or intangible. The purchase price of the founder shares was
determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares
outstanding was determined based on the expectation that the total size of this offering would be a maximum of 23,000,000 units
if the underwriters’ over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of
the outstanding ordinary shares after this offering. Up to 750,000 of the founder shares will be surrendered by our sponsor to us for
no consideration depending on the extent to which the underwriters’ over-allotment option is exercised. The post-offering percentages
in the following table assume that the underwriters do not exercise their over-allotment option, that 750,000 founder shares have been
surrendered by our sponsor to us for no consideration, and that there are